The longstanding issue of the benefit of ursodeoxycholic acid in primary sclerosing cholangitis: a long-term population-based study - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Evaluating the Efficacy of Ursodeoxycholic Acid in Primary Sclerosing Cholangitis: Findings from a Long-Term Population Study

  • By

  • Bregje Mol

  • Kim van Munster

  • Rinse Weersma

  • Akin Inderson

  • Kirsten Boonstra

  • Joost Drenth

  • Suzanne van Meer

  • Elsemieke de Vries

  • Marcel Spanier

  • Anton Vrij

  • Tessa Verlaan

  • Femke van Duijn

  • Willemijn Ponsioen

  • Marcel Dijkgraaf

  • Cyriel Ponsioen

  • June 15, 2026

Share

Original Source(s)

The longstanding issue of the benefit of ursodeoxycholic acid in primary sclerosing cholangitis: a long-term population-based study

  • by Bregje Mol, Kim van Munster, Rinse Weersma, Akin Inderson, Kirsten Boonstra, Joost Drenth, Suzanne van Meer, Elsemieke de Vries, Marcel Spanier, Anton Vrij, Tessa Verlaan, Femke van Duijn, Willemijn Ponsioen, Marcel Dijkgraaf, Cyriel Ponsioen

  • June 15, 2026

Related Content

Spleen volume-to-platelet count ratio correlates with portal pressure and is associated with blood loss in laparoscopic non-anatomical hepatectomy

Drug-associated inflammatory bowel disease: a real-world pharmacovigilance study using the FAERS and JADER databases

This Week's CGT News: World's First Solid Tumor CAR T Approved in China 

  • June 30, 2026

  • 6 min